Antihypertensives associated adverse events: a review of mechanisms and pharmacogenomic biomarkers available evidence in multi-ethnic populations
Hypertension remains a significant health burden worldwide, re-emphasizing the outstanding need for more effective and safer antihypertensive therapeutic approaches. Genetic variation contributes significantly to interindividual variability in treatment response and adverse events, suggesting pharma...
Saved in:
Main Authors: | Sahar M. Altoum (Author), Zeina N. Al-Mahayri (Author), Bassam R. Ali (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxicity and Pharmacogenomic Biomarkers in Breast Cancer Chemotherapy
by: Zeina N. Al-Mahayri, et al.
Published: (2020) -
Pharmacogenomics at the post-pandemic: If not now, then when?
by: Zeina N. Al-Mahayri
Published: (2022) -
Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations
by: George P. Patrinos, et al.
Published: (2023) -
Ethnic Diversity and Warfarin Pharmacogenomics
by: Innocent G. Asiimwe, et al.
Published: (2022) -
Hyperuricaemia, gout and related adverse events associated with antihypertensive drugs: A real-world analysis using the FDA adverse event reporting system
by: Xue-Feng Jiao, et al.
Published: (2023)